CTOs on the Move

Blessing Hospital

www.blessinghospital.com

 
Blessing Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Blessing Hospital is based in Quincy, IL. You can find more information on Blessing Hospital at www.blessinghospital.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details

Similar Companies

Norwell Visiting Nurse Association and Hospice

The only independent, free standing, non-profit home health care and hospice agency serving the South Shore, NVNA and Hospice provides care to over 27 communities from Milton to Plymouth. Ten-time winner of the national HomeCare Elite Top Agency award, Top 100 the last two years, NVNA and Hospice offers the full continuum of care from certified and private pay home care, to palliative and hospice care. Non-profit hospice residence, the Pat Roche Hospice Home, offers residential hospice care. Specialty services in Alzheimer`s, Diabetes, CHF, Chronic Disease Self Management, Wound Care, and Falls Prevention. Educational programs, free health screenings, and caregiver support groups also offered.

Mid Coast Health Services

Mid Coast Health Services is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Mid Coast Health Services is based in Brunswick, ME. You can find more information on Mid Coast Health Services at www.midcoasthealth.com

Cergis Billing

Cergis Billing is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Osso VR

Osso VR is an award winning VR surgical and medical device training platform. The company is made up of practicing clinicians, professional VR developers and medtech industry veterans. We specialize in hyper-realistic, haptic-enhanced, hands-on interactivity and design.

Catabasis

At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.